Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Bridge to Transplant Patients
Status: Enrolling
Updated:  12/31/1969
Intermountain Medical Center
mi
from
Salt Lake City, UT
Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Bridge to Transplant Patients
Status: Enrolling
Updated: 12/31/1969
Intermountain Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Bridge to Transplant Patients
Status: Enrolling
Updated:  12/31/1969
Sacred Heart Medical Center
mi
from
Spokane, WA
Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Bridge to Transplant Patients
Status: Enrolling
Updated: 12/31/1969
Sacred Heart Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Bridge to Transplant Patients
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
mi
from
Madison, WI
Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Bridge to Transplant Patients
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Bridge to Transplant Patients
Status: Enrolling
Updated:  12/31/1969
St. Luke's Medical Center
mi
from
Milwaukee, WI
Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Bridge to Transplant Patients
Status: Enrolling
Updated: 12/31/1969
St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
University Hospital of Alabama at Birmingham
mi
from
Birmingham, AL
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
University Hospital of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Baptist Health Medical Center
mi
from
Little Rock, AR
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Baptist Health Medical Center
mi
from
Little Rock, AR
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Arkansas Heart Hospital
mi
from
Little Rock, AR
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Arkansas Heart Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Glendale Memorial Medical Center
mi
from
Glendale, CA
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Glendale Memorial Medical Center
mi
from
Glendale, CA
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
ACS Research Group
mi
from
Mountain View, CA
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
ACS Research Group
mi
from
Mountain View, CA
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Regional Cardiology Associates
mi
from
Sacramento, CA
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Regional Cardiology Associates
mi
from
Sacramento, CA
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Scripps Green Hospital
mi
from
San Diego, CA
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Scripps Green Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Orlando Heart Center
mi
from
Orlando, FL
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Orlando Heart Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Piedmont Hospital
mi
from
Atlanta, GA
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Piedmont Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Midwest Heart Foundation
mi
from
Lombard, IL
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Midwest Heart Foundation
mi
from
Lombard, IL
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Central Baptist Hospital
mi
from
Lexington, KY
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Central Baptist Hospital
mi
from
Lexington, KY
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Lahey Clinical Medical Center
mi
from
Burlington, MA
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Lahey Clinical Medical Center
mi
from
Burlington, MA
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Thoracic & Cardiovascular Healthcare Foundation
mi
from
Lansing, MI
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Thoracic & Cardiovascular Healthcare Foundation
mi
from
Lansing, MI
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Deborah Heart and Lung Center
mi
from
Browns Mills, NJ
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Deborah Heart and Lung Center
mi
from
Browns Mills, NJ
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Morristown Memorial Hospital
mi
from
Morristown, NJ
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Morristown Memorial Hospital
mi
from
Morristown, NJ
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
EMH Regional Medical Center
mi
from
Elyria, OH
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
EMH Regional Medical Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Lancaster Heart Foundation
mi
from
Lancaster, PA
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Lancaster Heart Foundation
mi
from
Lancaster, PA
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Methodist University Hospital
mi
from
Memphis, TN
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Methodist University Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
St. Thomas Hospital
mi
from
Nashville, TN
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
St. Thomas Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
Arrhythmia Center for Southern Wisconsin
mi
from
Milwaukee, WI
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
Arrhythmia Center for Southern Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated:  12/31/1969
The Heart and Vascular Institute of Florida - S. Pinellas
mi
from
Saint Petersburg, FL
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Status: Enrolling
Updated: 12/31/1969
The Heart and Vascular Institute of Florida - S. Pinellas
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population
LSU HCSD Tele-Health Projects: Adult Systolic Heart Failure Patient Population
Status: Enrolling
Updated:  12/31/1969
Earl K. Long Medical Center
mi
from
Baton Rouge, LA
Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population
LSU HCSD Tele-Health Projects: Adult Systolic Heart Failure Patient Population
Status: Enrolling
Updated: 12/31/1969
Earl K. Long Medical Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population
LSU HCSD Tele-Health Projects: Adult Systolic Heart Failure Patient Population
Status: Enrolling
Updated:  12/31/1969
Leonard J. Chabert Medical Center
mi
from
Houma, LA
Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population
LSU HCSD Tele-Health Projects: Adult Systolic Heart Failure Patient Population
Status: Enrolling
Updated: 12/31/1969
Leonard J. Chabert Medical Center
mi
from
Houma, LA
Click here to add this to my saved trials
Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population
LSU HCSD Tele-Health Projects: Adult Systolic Heart Failure Patient Population
Status: Enrolling
Updated:  12/31/1969
University Medical Center
mi
from
Lafayette, LA
Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population
LSU HCSD Tele-Health Projects: Adult Systolic Heart Failure Patient Population
Status: Enrolling
Updated: 12/31/1969
University Medical Center
mi
from
Lafayette, LA
Click here to add this to my saved trials
Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population
LSU HCSD Tele-Health Projects: Adult Systolic Heart Failure Patient Population
Status: Enrolling
Updated:  12/31/1969
WO Moss Regional Medical Center
mi
from
Lake Charles, LA
Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population
LSU HCSD Tele-Health Projects: Adult Systolic Heart Failure Patient Population
Status: Enrolling
Updated: 12/31/1969
WO Moss Regional Medical Center
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.
Clinical Utility of an Age, Sex and Gene Expression Score (ASGES or Corus CAD) in the Diagnostic Management of Obstructive Coronary Artery Disease in African American Patients in a Primary Care Setting
Status: Enrolling
Updated:  12/31/1969
Providence Medical Group - Dayton Primary
mi
from
Dayton, OH
Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.
Clinical Utility of an Age, Sex and Gene Expression Score (ASGES or Corus CAD) in the Diagnostic Management of Obstructive Coronary Artery Disease in African American Patients in a Primary Care Setting
Status: Enrolling
Updated: 12/31/1969
Providence Medical Group - Dayton Primary
mi
from
Dayton, OH
Click here to add this to my saved trials
Effects of Carbon Monoxide Breathing on Blood Vessel Function
Effects of Carbon Monoxide Breathing on Blood Vessel Function
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Effects of Carbon Monoxide Breathing on Blood Vessel Function
Effects of Carbon Monoxide Breathing on Blood Vessel Function
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Different Approach to Preventing Thrombosis
A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Controlled Trial Comparing Low Molecular Weight Heparin to Acetylsalicylic Acid in Orthopedic Trauma Patients
Status: Enrolling
Updated:  12/31/1969
University of Maryland Medical Center
mi
from
Baltimore, MD
A Different Approach to Preventing Thrombosis
A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Controlled Trial Comparing Low Molecular Weight Heparin to Acetylsalicylic Acid in Orthopedic Trauma Patients
Status: Enrolling
Updated: 12/31/1969
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases
Status: Enrolling
Updated:  12/31/1969
UCLA Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases
Status: Enrolling
Updated: 12/31/1969
UCLA Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Failure Study
CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Study
Status: Enrolling
Updated:  12/31/1969
Boston University
mi
from
Boston, MA
CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Failure Study
CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Study
Status: Enrolling
Updated: 12/31/1969
Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Cardiology PC
mi
from
Birmingham, AL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Cardiology PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Hospital
mi
from
Phoenix, AZ
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Scripps Green Hospital / Scripps Clinical Hospital
mi
from
La Jolla, CA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Scripps Green Hospital / Scripps Clinical Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Stanford university Hospital and Clinics
mi
from
Stanford, CA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Gainesville, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
University of Florida Health Science Center
mi
from
Jacksonville, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
University of Florida Health Science Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Institute Florida Hospital
mi
from
Orlando, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Institute Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
The Medical Group of St. Joseph´s
mi
from
Atlanta, GA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
The Medical Group of St. Joseph´s
mi
from
Atlanta, GA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Northwestern University Med School
mi
from
Chicago, IL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Northwestern University Med School
mi
from
Chicago, IL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Caritas St. Elizabeth´s Medical Center
mi
from
Boston, MA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Caritas St. Elizabeth´s Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials